FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1724331497> ?p ?o ?g. }

• W1724331497 endingPage "763" @default.
• W1724331497 startingPage "758" @default.
• W1724331497 abstract "Children/adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL) have an excellent prognosis but relapses still occur. While chromosomal aberrations and/or clonal immunoglobulin (Ig) gene rearrangements may indicate risk of failure, a more universal approach was developed to detect minimal disease (MD). Children/adolescents with intermediate-risk B-NHL were treated with French-British-American/Lymphome Malins de Burkitt 96 (FAB/LMB96) B4 modified chemotherapy and rituximab. Specimens from diagnosis, end of induction (EOI), and end of therapy (EOT) were assayed for MD. Initial specimens were screened for IGHV family usage with primer pools followed by individual primers to identify MD. Thirty-two diagnostic/staging specimens screened positive with primer pools and unique IGHV family primers were identified. Two patients relapsed; first relapse (4 months from diagnosis) was MD-positive at EOI, the second (36 months from diagnosis) was MD-positive at EOT. At EOI, recurrent rates were similar between the MRD-positive and MRD-negative patients (P = 0·40). At EOT, only 13/32 patients had MRD data available with one relapse in the MRD-positive group and no recurrences in the MRD-negative group (P = 0·077). The study demonstrated molecular-disseminated disease in which IgIGHV primer pools could be used to assess MD. This feasibility study supports future investigations to assess the validity and significance of MD screening in a larger cohort of patients with intermediate-risk mature B-NHL." @default.
• W1724331497 created "2016-06-24" @default.
• W1724331497 creator A5001697191 @default.
• W1724331497 creator A5015539225 @default.
• W1724331497 creator A5016749720 @default.
• W1724331497 creator A5017386283 @default.
• W1724331497 creator A5021489854 @default.
• W1724331497 creator A5023129428 @default.
• W1724331497 creator A5036250651 @default.
• W1724331497 creator A5041701143 @default.
• W1724331497 creator A5049270053 @default.
• W1724331497 creator A5060291120 @default.
• W1724331497 creator A5073848195 @default.
• W1724331497 creator A5080068885 @default.
• W1724331497 date "2011-04-18" @default.
• W1724331497 modified "2023-10-17" @default.
• W1724331497 title "Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children’s oncology group report" @default.
• W1724331497 cites W1974184061 @default.
• W1724331497 cites W2000871066 @default.
• W1724331497 cites W2001101301 @default.
• W1724331497 cites W2003190680 @default.
• W1724331497 cites W2029846811 @default.
• W1724331497 cites W2039212724 @default.
• W1724331497 cites W2039642633 @default.
• W1724331497 cites W2045940197 @default.
• W1724331497 cites W2062032144 @default.
• W1724331497 cites W2062308740 @default.
• W1724331497 cites W2107692941 @default.
• W1724331497 cites W2111128465 @default.
• W1724331497 cites W2136725907 @default.
• W1724331497 cites W2143502805 @default.
• W1724331497 cites W2156073127 @default.
• W1724331497 cites W2274586391 @default.
• W1724331497 cites W2335416848 @default.
• W1724331497 cites W2590873232 @default.
• W1724331497 doi "https://doi.org/10.1111/j.1365-2141.2011.08681.x" @default.
• W1724331497 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3103617" @default.
• W1724331497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21496005" @default.
• W1724331497 hasPublicationYear "2011" @default.
• W1724331497 type Work @default.
• W1724331497 sameAs 1724331497 @default.
• W1724331497 citedByCount "31" @default.
• W1724331497 countsByYear W17243314972012 @default.
• W1724331497 countsByYear W17243314972013 @default.
• W1724331497 countsByYear W17243314972014 @default.
• W1724331497 countsByYear W17243314972015 @default.
• W1724331497 countsByYear W17243314972016 @default.
• W1724331497 countsByYear W17243314972017 @default.
• W1724331497 countsByYear W17243314972018 @default.
• W1724331497 countsByYear W17243314972019 @default.
• W1724331497 countsByYear W17243314972020 @default.
• W1724331497 countsByYear W17243314972023 @default.
• W1724331497 crossrefType "journal-article" @default.
• W1724331497 hasAuthorship W1724331497A5001697191 @default.
• W1724331497 hasAuthorship W1724331497A5015539225 @default.
• W1724331497 hasAuthorship W1724331497A5016749720 @default.
• W1724331497 hasAuthorship W1724331497A5017386283 @default.
• W1724331497 hasAuthorship W1724331497A5021489854 @default.
• W1724331497 hasAuthorship W1724331497A5023129428 @default.
• W1724331497 hasAuthorship W1724331497A5036250651 @default.
• W1724331497 hasAuthorship W1724331497A5041701143 @default.
• W1724331497 hasAuthorship W1724331497A5049270053 @default.
• W1724331497 hasAuthorship W1724331497A5060291120 @default.
• W1724331497 hasAuthorship W1724331497A5073848195 @default.
• W1724331497 hasAuthorship W1724331497A5080068885 @default.
• W1724331497 hasBestOaLocation W17243314971 @default.
• W1724331497 hasConcept C126322002 @default.
• W1724331497 hasConcept C143998085 @default.
• W1724331497 hasConcept C146357865 @default.
• W1724331497 hasConcept C151730666 @default.
• W1724331497 hasConcept C203014093 @default.
• W1724331497 hasConcept C2776694085 @default.
• W1724331497 hasConcept C2778461978 @default.
• W1724331497 hasConcept C2779134260 @default.
• W1724331497 hasConcept C2779338263 @default.
• W1724331497 hasConcept C2779823535 @default.
• W1724331497 hasConcept C2780653079 @default.
• W1724331497 hasConcept C71924100 @default.
• W1724331497 hasConcept C86803240 @default.
• W1724331497 hasConceptScore W1724331497C126322002 @default.
• W1724331497 hasConceptScore W1724331497C143998085 @default.
• W1724331497 hasConceptScore W1724331497C146357865 @default.
• W1724331497 hasConceptScore W1724331497C151730666 @default.
• W1724331497 hasConceptScore W1724331497C203014093 @default.
• W1724331497 hasConceptScore W1724331497C2776694085 @default.
• W1724331497 hasConceptScore W1724331497C2778461978 @default.
• W1724331497 hasConceptScore W1724331497C2779134260 @default.
• W1724331497 hasConceptScore W1724331497C2779338263 @default.
• W1724331497 hasConceptScore W1724331497C2779823535 @default.
• W1724331497 hasConceptScore W1724331497C2780653079 @default.
• W1724331497 hasConceptScore W1724331497C71924100 @default.
• W1724331497 hasConceptScore W1724331497C86803240 @default.
• W1724331497 hasIssue "6" @default.
• W1724331497 hasLocation W17243314971 @default.
• W1724331497 hasLocation W17243314972 @default.
• W1724331497 hasLocation W17243314973 @default.
• W1724331497 hasLocation W17243314974 @default.
• W1724331497 hasOpenAccess W1724331497 @default.

• next